US Stock MarketDetailed Quotes
ETON Eton Pharmaceutical
- 12.740
- +0.290+2.33%
Close Nov 27 16:00 ET
- 12.550
- -0.190-1.49%
Post 16:59 ET
329.15MMarket Cap-60666P/E (TTM)
12.770High12.150Low186.74KVolume12.470Open12.450Pre Close2.33MTurnover0.86%Turnover RatioLossP/E (Static)25.84MShares12.77052wk High20.58P/B276.30MFloat Cap3.03052wk Low--Dividend TTM21.69MShs Float12.770Historical High--Div YieldTTM4.98%Amplitude1.950Historical Low12.497Avg Price1Lot Size
About Eton Pharmaceutical Company
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Company Profile
SymbolETON
Company NameEton Pharmaceutical
Listing DateNov 13, 2018
Issue Price6.00
Founded2017
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address21925 West Field Parkway,Suite 235
CityDeer Park
ProvinceIllinois
CountryUnited States of America
Zip Code60010-7278
Phone1-847-787-7361
Websitehttp://www.etonpharma.com
Company Executives
- Name
- Position
- Salary
- Sean E. Brynjelsen
- President, Chief Executive Officer and Director
- 1.75M
- James R. Gruber
- Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
- 785.14K
- David C. Krempa
- Chief Business Officer
- 719.08K
- Dr. Norbert G. Riedel,PhD
- Chairman of the Board
- 155.50K
- Jennifer McKie Adams
- Independent Director
- 119.10K
- Paul Victor Maier
- Independent Director
- 129.50K
- Charles J. Casamento
- Independent Director
- 126.90K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data